Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
SEC STAFF LETTER - THAI YEE HONG TECHNOLOGY HOLDINGS PTE LTD (0002081842) (Filer)
8-K - SHINECO, INC. (0001300734) (Filer)
10-K - SHINECO, INC. (0001300734) (Filer)
3 - SHINECO, INC. (0001300734) (Issuer)
3 - SHINECO, INC. (0001300734) (Issuer)
3 - SHINECO, INC. (0001300734) (Issuer)
BEIJING, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products and other biotech products, announced that its ticker symbol on the Nasdaq Stock Market (NASDAQ) will change to "SISI" at the open of market trading on Monday, October 18, 2021. Shineco has traded under the ticker "TYHT" since the Company's initial public offering in 2016. Ms. Jennifer Zhan, CEO of Shineco, commented, "We are pleased to see that our ticker symbol is now aligned with our brand and our vision, which will strengthen our visibility with public investors and provide consistent recogni
BEIJING, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products and other biotech products, announced that it entered into a framework agreement (the "Framework Agreement") on October 4, 2021, to acquire over 51% equity interest of Beijing Wonner Biotech Co., Ltd. ("Beijing Wonner") with no more than $30 million, to jointly develop SNG, a rapid-acting antidepressant natural innovative medicine. The final purchase price will be separately determined based on the evaluation report issued by a third party. Beijing Wonner is a biotechnology company engage
BEIJING, June 01, 2021 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products, today announced in response to unusual market activity, and after speaking with its officers, directors, major shareholders and other relevant persons, that it is unaware of the reason behind recent stock price volatility. The Company confirms that there is no corporate development relating to its business and affairs that has not been previously announced. About Shineco, Inc. Incorporated in Delaware in August 1997 and headquartered in Beijing, China, Shineco is a holding company. Through its
BEIJING, May 07, 2021 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products, today announced that Mr. Guocong Zhou had step down as CEO of the Company, effective May 5, 2021. He was succeeded by Ms. Ou Yang, who has extensive experience in the capital market and the healthcare industry, on May 6, 2021. Ms. Ou Yang has served as a partner of Wuhan Sinopharm Optical Valley Capital Management Co., Ltd., a subsidiary of China National Pharmaceutical Group Corporation and an equity investment institution focusing on the medical and healthcare field, since January 2020 and has